|
English
|
正體中文
|
简体中文
|
2815039
|
|
???header.visitor??? :
27338146
???header.onlineuser??? :
523
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"miyagawa t"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2020-02-26T01:32:53Z |
Preparation of arginine–glycine–aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization
|
Chang, C.-Y.;Wang, M.-C.;Miyagawa, T.;Chen, Z.-Y.;Lin, F.-H.;Chen, K.-H.;Liu, G.-S.;Tseng, C.-L.Feng-Huei Lin; Chang, C.-Y.; Wang, M.-C.; Miyagawa, T.; Chen, Z.-Y.; Lin, F.-H.; Chen, K.-H.; Liu, G.-S.; Tseng, C.-L.; FENG-HUEI LIN |
| 國立成功大學 |
2020 |
Topical application of hyaluronic acid-RGD peptide-coated gelatin/epigallocatechin-3 gallate (EGCG) nanoparticles inhibits corneal neovascularization via inhibition of VEGF production
|
Miyagawa, T.;Chen, Z.-Y.;Chang, Chang C.-Y.;Chen, K.-H.;Wang, Y.-K.;Liu, G.-S.;Tseng, C.-L. |
| 國家衛生研究院 |
2016-12-30 |
Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization
|
Chang, CY;Wang, MC;Miyagawa, T;Chen, ZY;Lin, FH;Chen, KH;Liu, GS;Tseng, CL |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
